SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

VARANI, Katia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 48.509
AS - Asia 26.418
EU - Europa 16.711
SA - Sud America 4.084
Continente sconosciuto - Info sul continente non disponibili 766
AF - Africa 552
OC - Oceania 46
AN - Antartide 1
Totale 97.087
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 47.321
SG - Singapore 9.375
CN - Cina 6.786
BR - Brasile 3.138
VN - Vietnam 3.031
DE - Germania 2.990
FI - Finlandia 2.929
IT - Italia 2.654
UA - Ucraina 2.390
HK - Hong Kong 2.167
TR - Turchia 1.934
GB - Regno Unito 1.492
FR - Francia 950
SE - Svezia 947
RU - Federazione Russa 755
BD - Bangladesh 634
JP - Giappone 634
CA - Canada 596
IN - India 537
PL - Polonia 532
MX - Messico 384
AR - Argentina 341
ID - Indonesia 248
NL - Olanda 245
ZA - Sudafrica 203
IQ - Iraq 187
ES - Italia 160
EC - Ecuador 150
CO - Colombia 133
BE - Belgio 128
PK - Pakistan 113
LT - Lituania 98
VE - Venezuela 97
UZ - Uzbekistan 90
MA - Marocco 85
SA - Arabia Saudita 81
AT - Austria 78
CZ - Repubblica Ceca 73
MY - Malesia 72
CL - Cile 71
PH - Filippine 69
AE - Emirati Arabi Uniti 67
TN - Tunisia 61
PY - Paraguay 54
KE - Kenya 53
JO - Giordania 43
JM - Giamaica 41
AU - Australia 35
CR - Costa Rica 33
IL - Israele 33
UY - Uruguay 33
CH - Svizzera 32
EG - Egitto 32
KR - Corea 32
PE - Perù 32
NP - Nepal 31
IE - Irlanda 30
DZ - Algeria 29
BO - Bolivia 28
IR - Iran 26
HN - Honduras 25
RO - Romania 25
AL - Albania 24
TW - Taiwan 23
AZ - Azerbaigian 22
PT - Portogallo 20
KZ - Kazakistan 19
TT - Trinidad e Tobago 19
EU - Europa 18
TH - Thailandia 18
ET - Etiopia 17
BG - Bulgaria 15
KG - Kirghizistan 15
LB - Libano 15
OM - Oman 15
BH - Bahrain 14
DO - Repubblica Dominicana 14
PS - Palestinian Territory 14
RS - Serbia 14
SY - Repubblica araba siriana 14
GT - Guatemala 13
HU - Ungheria 13
LV - Lettonia 13
HR - Croazia 12
NO - Norvegia 12
BA - Bosnia-Erzegovina 11
BY - Bielorussia 11
GR - Grecia 11
MD - Moldavia 11
SV - El Salvador 11
CI - Costa d'Avorio 10
SN - Senegal 10
AM - Armenia 9
NI - Nicaragua 9
PA - Panama 9
AO - Angola 8
CG - Congo 8
NZ - Nuova Zelanda 8
PR - Porto Rico 8
QA - Qatar 8
Totale 96.188
Salva come PNG Salva come JPEG
Città #
Singapore 6.058
Ashburn 5.010
Woodbridge 3.959
Fairfield 3.397
San Jose 3.018
Jacksonville 2.617
Chandler 2.500
Houston 2.457
Helsinki 2.234
Ann Arbor 2.135
Hong Kong 2.123
Beijing 2.064
Santa Clara 2.017
Dallas 1.541
Wilmington 1.429
Seattle 1.362
Cambridge 1.111
Council Bluffs 1.054
Ho Chi Minh City 989
Izmir 897
Los Angeles 849
Nanjing 786
Hanoi 702
New York 636
Tokyo 605
Princeton 587
Ferrara 527
Munich 527
Lauterbourg 486
Warsaw 484
Boardman 479
Milan 411
Shanghai 322
São Paulo 322
San Diego 311
Nanchang 252
Orem 248
Shenyang 236
Mexico City 234
London 203
Buffalo 198
Tianjin 191
Turku 188
Toronto 180
Dearborn 179
Chicago 175
Hefei 174
Bremen 167
Montreal 165
Frankfurt am Main 160
Changsha 158
Chennai 156
Falkenstein 153
The Dalles 152
Hebei 148
Brooklyn 146
Jakarta 144
Da Nang 143
Addison 140
Jiaxing 138
Denver 135
Haiphong 128
Atlanta 122
Brussels 122
San Francisco 113
Johannesburg 108
Phoenix 108
Rome 106
Manchester 103
Moscow 99
San Mateo 99
Stockholm 97
Jinan 95
Rio de Janeiro 95
Zhengzhou 93
Falls Church 90
Bologna 86
Norwalk 85
Amsterdam 83
Kunming 82
Dong Ket 81
Tashkent 80
Boston 78
Poplar 78
Baghdad 76
Guangzhou 76
Mountain View 70
Philadelphia 65
Ankara 64
Biên Hòa 62
Columbus 60
Auburn Hills 59
Belo Horizonte 59
Düsseldorf 58
Orange 58
Washington 57
Hải Dương 56
Ningbo 55
Mumbai 53
Quito 51
Totale 63.779
Salva come PNG Salva come JPEG
Nome #
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 3.111
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 424
Pharmacology of Adenosine Receptors: The State of the Art 418
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors 380
Dose and time effects of caffeine intake on human platelet adenosine A2A receptors: functional and biochemical aspects 343
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 330
Caffeine alters A(2A) adenosine receptors and their function in human platelets 330
A glance at adenosine receptors: Novel target for antitumor therapy 320
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 315
Alterazioni dei recettori alfa(2) adrenergici delle piastrine umane nell'ipertensione essenziale 310
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 308
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 304
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 294
The A3 adenosine receptor: history and perspectives 294
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 291
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice 290
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 283
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluation 280
Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice 278
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 276
Recettori e trasduzione del segnale 275
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice 274
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 269
A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release 267
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields 266
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 266
Pulsed Electromagnetic Fields: A Novel Attractive Therapeutic Opportunity for Neuroprotection After Acute Cerebral Ischemia 266
Repeated dosing with NCX1404, a nitric oxide-donating pregabalin, re-establishes normal nociceptive responses in mice with streptozotocin-induced painful diabetic neuropathy 264
Recettori e trasduzione del segnale 263
Adenosine receptors and human melanoma 262
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 258
A1 and A3 adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes 257
Adenosine analogs and electromagnetic fields inhibit prostaglandin E2 release in bovine synovial fibroblasts 257
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 257
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles 257
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 256
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 249
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 249
A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats 249
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 249
6-Amino-2-mercapto-3H-pyrimidin-4-one derivatives as new candidates for the antagonism at the P2Y12 receptors 248
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 247
History and perspectives of A2A adenosine receptor antagonists as potential therapeutic agents 245
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 245
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 245
Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes. 245
A(2A) adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients 244
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 243
Ala scan analogues of HOE 140. Synthesis and biological activities 242
Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies 241
Comparison of prazosin, terazosin and tamsulosin: Functional and binding studies in isolated prostatic and vascular human tissues 240
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 240
Adenosine A1 receptors in the rat brain in the kindling model of epilepsy 240
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 239
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 237
5-heteroarylcarbamoylamino-pyrazolo-triazolo pyrimidines as hA3 adenosine receptor antagonists. 236
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 234
Adenosine signaling contributes to ethanol-induced fatty liver in mice 232
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 232
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 230
Biological activity of for-Met-Leu-Phe-OMe analogs: relevant substitutions specifically trigger killing mechanisms in human neutrophils 230
HIF-1 neuroprotection through erythropoietin increase in hypoxia: a role for A1 adenosine receptors 229
A3 Receptors are Overexpressed in Pleura from Mesothelioma Patients and Reduce Cell Growth via Akt/NF-kB Pathway. 227
Adenosine receptor targeting in health and disease 227
Structural refinement of pyrazolo[4,3-d]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A3 adenosine receptor 227
Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A2A Adenosine Receptor Inverse Agonists with Antinociceptive Activity 226
Current status of A1 adenosine receptor allosteric enhancers 225
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands 224
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 224
A3 adenosine receptors are overexpressed in pleura from patients with mesothelioma and reduce malignant mesothelioma cell growth 223
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 222
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 222
van't Hoff Based Thermodynamics 222
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 222
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 221
[3H]-MRE 2029-F20, a novel selective antagonist radioligand, for the pharmacological and biochemical characterization of A2B receptors. 221
Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertension 220
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 220
A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus 220
7-substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A(2A) adenosine receptor antagonists: A study on the importance of modifications at the side chain on the activity and solubility 220
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 219
Pathological overproduction: the bad side of adenosine 219
Asymmetrical nitrido tc-99m heterocomplexes as potential imaging agents for benzodiazepine receptors 218
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 218
Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors 218
Targeting A3 and A2A adenosine receptors in the fight against cancer 218
Structure-activity relationship studies of a new series of imidazo[2,1-f] purinones as potent and selective A3 adenosine receptor antagonists 217
P2X1 and P2X3 Purinergic Receptors Differentially Modulate the Inflammatory Response in Human Osteoarthritic Synovial Fibroblasts 217
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 216
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 216
3H SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranes 216
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields 216
Agonists and antagonists: Molecular mechanisms and therapeutic applications 216
4-Amido-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-ones as new potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies 215
Adenosine modulates HIF-1, VEGF, IL-8 and foam cells formation in a human model of hypoxic foam cells 215
Receptor binding at two different temperatures to discriminate agonist and antagonist behaviour of adenosine A1 receptor ligands in rat brain 214
7-substituted-5-amino-2-(furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: importance of modifications at the side chain on the activity and solubility. 214
Microwave-assisted synthesis of thieno[2,3-c]pyridine derivatives as a new series of allosteric enhancers at the adenosine A(1) receptor 214
Electrophysiological basis for the enhanced cardiac arrhythmogenic effect of isoprenaline in aged spontaneously hypertensive rats 213
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells 212
Totale 27.987
Salva come PNG Salva come JPEG
Categoria #
all - tutte 411.287
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 9.074
Totale 420.361
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.019 0 552 340 225 245 210 232 269 193 432 731 1.590
2022/20235.734 592 432 176 795 954 821 269 458 700 46 296 195
2023/20242.851 289 377 142 83 316 343 136 209 57 72 77 750
2024/202512.275 311 354 946 618 1.431 1.133 460 739 1.729 1.390 1.711 1.453
2025/202637.587 3.432 1.629 3.585 4.462 4.967 2.339 3.975 1.789 5.243 3.973 1.420 773
2026/20272.852 1.253 1.599 0 0 0 0 0 0 0 0 0 0
Totale 97.087